| The cancer glycocalyx mechanically primes integrin-mediated growth and survival MJ Paszek, CC DuFort, O Rossier, R Bainer, JK Mouw, K Godula, ... Nature 511 (7509), 319-325, 2014 | 704 | 2014 |
| Increased telomerase activity and comprehensive lifestyle changes: a pilot study D Ornish, J Lin, J Daubenmier, G Weidner, E Epel, C Kemp, ... The lancet oncology 9 (11), 1048-1057, 2008 | 595 | 2008 |
| Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot … D Ornish, J Lin, JM Chan, E Epel, C Kemp, G Weidner, R Marlin, ... The lancet oncology 14 (11), 1112-1120, 2013 | 518 | 2013 |
| Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention D Ornish, MJM Magbanua, G Weidner, V Weinberg, C Kemp, C Green, ... Proceedings of the National Academy of Sciences 105 (24), 8369-8374, 2008 | 485 | 2008 |
| Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival MJM Magbanua, LB Swigart, HT Wu, GL Hirst, C Yau, DM Wolf, A Tin, ... Annals of Oncology 32 (2), 229-239, 2021 | 264 | 2021 |
| Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis FC Bidard, S Michiels, S Riethdorf, V Mueller, LJ Esserman, A Lucci, ... JNCI: Journal of the National Cancer Institute 110 (6), 560-567, 2018 | 260 | 2018 |
| Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls RK Kelley, MJM Magbanua, TM Butler, EA Collisson, J Hwang, ... BMC cancer 15, 1-11, 2015 | 123 | 2015 |
| Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies DM Wolf, C Yau, J Wulfkuhle, L Brown-Swigart, RI Gallagher, PRE Lee, ... Cancer Cell 40 (6), 609-623. e6, 2022 | 119 | 2022 |
| Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer MJM Magbanua, EV Sosa, JH Scott, J Simko, C Collins, D Pinkel, ... BMC cancer 12, 1-12, 2012 | 107 | 2012 |
| Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients MJM Magbanua, EV Sosa, R Roy, LE Eisenbud, JH Scott, A Olshen, ... Cancer research 73 (1), 30-40, 2013 | 106 | 2013 |
| Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response MJM Magbanua, DM Wolf, C Yau, SE Davis, J Crothers, A Au, CM Haqq, ... Breast Cancer Research 17, 1-13, 2015 | 83 | 2015 |
| Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation MJM Magbanua, R Roy, EV Sosa, V Weinberg, S Federman, MD Mattie, ... PloS one 6 (9), e24004, 2011 | 75 | 2011 |
| Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in … M Magbanua, L Brown-Swigart, G Hirst, C Yau, D Wolf, A Ma, E Bergin, ... Data presented at spotlight session: San Antonio Breast Cancer Symposium, 2018 | 69 | 2018 |
| Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer JS Lee, ME Melisko, MJM Magbanua, AT Kablanian, JH Scott, HS Rugo, ... Breast cancer research and treatment 154, 339-349, 2015 | 69 | 2015 |
| Physical activity and prostate gene expression in men with low-risk prostate cancer MJM Magbanua, EL Richman, EV Sosa, LW Jones, J Simko, K Shinohara, ... Cancer Causes & Control 25, 515-523, 2014 | 65 | 2014 |
| Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer JM Chan, V Weinberg, MJ Magbanua, E Sosa, J Simko, K Shinohara, ... Cancer causes & control 22, 141-150, 2011 | 63 | 2011 |
| Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis MJM Magbanua, M Melisko, R Roy, EV Sosa, L Hauranieh, A Kablanian, ... Cancer research 73 (23), 7134-7143, 2013 | 61 | 2013 |
| Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance P Stejskal, H Goodarzi, J Srovnal, M Hajdśch, LJ van’t Veer, ... Molecular cancer 22 (1), 15, 2023 | 57 | 2023 |
| Quantitative whole genome sequencing of circulating tumor cells enables personalized combination therapy of metastatic cancer N Gulbahce, MJM Magbanua, R Chin, MR Agarwal, X Luo, J Liu, ... Cancer research 77 (16), 4530-4541, 2017 | 56 | 2017 |
| Expression profiling of circulating tumor cells in metastatic breast cancer JE Lang, JH Scott, DM Wolf, P Novak, V Punj, MJM Magbanua, W Zhu, ... Breast cancer research and treatment 149, 121-131, 2015 | 55 | 2015 |
